BIO Welcomes Advances in Stem Cell Research

  • Contact: Contact Stephanie Fischer
    (202) 312-9263
  • Recommend
  • Tweet
  • Print
  • Email

WASHINGTON, D.C. (Friday, August 08, 2008) - BIO President and CEO Jim Greenwood issued the following statement regarding the news that researchers at the Harvard Stem Cell Institute created 20 disease-specific stem cell lines thru the new induced pluripotent stem cell (iPS) technique:

“The creation of stem cells lines carrying the genes or genetic components of ten diseases is a great step forward in the quest to understand, treat and eventually cure disease.  We commend the Institute for their research and for making these stem cell lines available to researchers around the world to study.

“As the researchers have noted, while these stem cell lines were created thru iPS, we should not abandon other promising areas of research such as embryonic stem cell research. We must do all we can to accelerate research and explore all avenues of therapeutic possibilities to their fullest to determine which areas can present treatment options fastest. 

“BIO will continue to support and advocate for increased funding for all promising areas of therapeutic research.”

Upcoming BIO Events


Pacific Rim Summit on Industrial Biotechnology and Bioenergy

Sept. 10-12, 2008
Vancouver, BC, Canada 

Intellectual Property Council Committee Fall Conference and Meeting
October 20-22, 2008
Orlando, Fla.

BIO HR Conference 2008
October 26-28, 2008
San Diego, Calif.

Advanced Business Development Course
October 27-29, 2008
San Francisco, Calif.

BIO Investor Forum 2008
October 29-31, 2008
San Francisco, Calif.

Advanced Business Development Course
November 14-16, 2008
Mannheim/Heidelberg, Germany

BIO-Europe 2008
November 17-19, 2008
Mannheim/Heidelberg, Germany

2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga.


About BIO

 

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

###

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.